[U40-7-1] The combined immunotherapy based on integrated immune ratio in pancreatic cancer delays tumor growth and enhances its prognosis
The password is described in the Program Book.
Please refer to page 5.
U-40 Oral
2018年6月9日(土) 10:00 〜 10:50 Room 4 (4F, 411+412)
Chairs: Masamichi Mizuma (Department of Surgery, Tohoku University), Junpei Yamaguchi (Nagoya University Graduate School of Medicine, Surgical Oncology)
The password is described in the Program Book.
Please refer to page 5.